Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 41.40
-0.25 (-0.60%)
Mar 26, 2026, 1:30 PM CST
Center Laboratories Revenue
In the year 2025, Center Laboratories had annual revenue of 1.52B TWD, down -6.28%. Center Laboratories had revenue of 399.51M in the quarter ending December 31, 2025, a decrease of -10.93%.
Revenue
1.52B
Revenue Growth
-6.28%
P/S Ratio
20.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | -101.68M | -6.28% |
| Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
| Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
| Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
| Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.16B |